No Data
Jinhua Enterprise (Group) Co., Ltd. Report for the Third Quarter of 2024
ginwa enterprise(group) inc. (600080.SH): net income of 30.77 million yuan in the first three quarters, a year-on-year increase of 807.59%.
Gelonghui on October 29th: Ginwa Enterprise(Group) Inc. (600080.SH) released its third-quarter report. The revenue for the first three quarters was 0.419 billion yuan, a year-on-year increase of 4.00%. The net income was 30.77 million yuan, a year-on-year increase of 807.59%. The non-net profit was 17.3687 million yuan, a year-on-year decrease of 13.23%, with basic earnings per share of 0.0840 yuan.
Ginwa enterprise(group) inc. (600080.SH) released its performance for the first three quarters, with a net income of 30.77 million yuan, a year-on-year increase of 807.59%.
ginwa enterprise(group) inc. (600080.SH) disclosed the third quarter report for 2024, achieving revenue of 4....
Summary of the Semi-Annual Report of Jinhua Enterprise (Group) Co., Ltd. in 2024.
Interim report of JinHua Enterprise (Group) Co., Ltd. for the first half of 2024.
Ginwa Enterprise(Group) Inc. (600080.SH) recorded a net income of 9.4629 million yuan in the first half of the year, a year-on-year increase of 211.01%.
Ginwa Enterprise(Group) Inc. (600080.SH) released its 2024 interim report on August 16th, reporting revenue of CNY 0.246 billion, a 3.68% YoY decrease; net income attributable to shareholders of listed companies was CNY 9.4629 million, a 211.01% YoY increase; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was CNY 10.0314 million, a 42.39% YoY decrease; and a basic EPS of CNY 0.0261. The company's leading product, Jintiange Capsule, is a national Class I new drug and has become a first-line Traditional Chinese Medicine in orthopedic clinical use after years of promotion; the transfer is due to ...
Some Confidence Is Lacking In Ginwa Enterprise (Group) Inc. (SHSE:600080) As Shares Slide 29%No Data
No Data
